INVESTOR NEWS

Sep 02, 2020

Gentian Diagnostics presents at the Pareto Healtcare conference

Moss 02.09.20

Aug 27, 2020

STUDY CONFIRMS SIGNIFICANTLY ELEVATED LEVELS OF CALPROTECTIN IN PATIENTS WITH SEVERE COVID-19

Moss, 27.08.20

Aug 21, 2020

Second quarter and first half 2020 financial report

Moss, 21 August 2020

Aug 14, 2020

Presentation of second quarter and first half results for 2020 for Gentian Diagnostics AS

Gentian Diagnostics AS will present its second quarter and first half results for 2020 on August 21st at..

Jul 03, 2020

Gentian awarded up to NOK 8.0 million funding to develop a novel high-throughput COVID-19 antibody test

Moss, 3 July 2020

Jun 16, 2020

Release of BÜHLMANN fPELA® turbo

 Moss 16.06.2020

May 14, 2020

MINUTES OF ANNUAL GENERAL MEETING

The Annual General Meeting of Gentian Diagnostics AS was held 14 May 2020. All proposed resolutions on the..

Apr 29, 2020

Notice of Annual General Meeting

The 2020 Annual General Meeting of Gentian Diagnostics AS will be held on 14 May 2020 at 10:00 (CEST) at..

Apr 24, 2020

2019 Annual Report

The Board of Gentian Diagnostics AS has approved the Annual Report for 2019. The Annual Report is without..

Apr 24, 2020

First quarter 2020 financial report

Moss, 24 April 2020 Gentian Diagnostics AS announces its results for the first quarter of 2020.